# Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD

> **NCT01239030** · PHASE3 · COMPLETED · sponsor: **Rhodes Pharmaceuticals, L.P.** · enrollment: 230 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder
- ADHD

## Interventions

- **DRUG:** Methylphenidate Hydrochloride Extended Release Capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01239030
- **Lead sponsor:** Rhodes Pharmaceuticals, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01239030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01239030, "Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01239030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*